Dr. Lilia M. Correa, MD

Dr. Correa practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Correa's NPI, 1316203110, was assigned on April 5, 2012. Dr. Correa graduated from Central University of Venezuela in 2001. Dr. Correa holds Florida license ME133636.

Dr. Correa's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Correa also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Correa's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dr. Correa is also affiliated with Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Correa to 2 more group practices and clinics, 1 breast imaging center, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Correa practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Correa's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Correa is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Correa's licenses on file in 3 states: Florida, New Jersey and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and minor injury to a limb among the conditions Dr. Correa treats.

CMS data shows 1,955 Medicare services from Dr. Correa across 22 procedure codes in 2024, for 439 Medicare patients. Medicare paid $168,623 for them.

CMS counts 439 Medicare patients who saw Dr. Correa in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Correa's median patient age at 70, with 58% women.

In 2024, Dr. Correa wrote 873 Medicare Part D claims for 260 patients. 88% of them were for generic drugs. CMS names the drug for 684 of them, across 28 drugs with 11 or more claims each, at $253,005 in total drug cost. In 2023, CMS named 435 claims across 15 drugs.

Dr. Correa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Correa as offering telehealth. CMS counts 85 procedures of melanoma (skin cancer) excision by Dr. Correa, more than 91% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Correa, published from 2022 to 2025. Dr. Correa's most frequent co-authors are Chih-Shan J. Chen, MD, Bahar Fatemeh Firoz, MD, MPH and James M. Grichnik, MD.

CMS Open Payments shows 94 general payments to Dr. Correa from 37 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. AccuTec Blades Inc paid the most, $12,000. It also lists 17 research payments totaling $11,248 from 2024 to 2025, naming 2 clinical trials.

Dr. Correa graduated from Central University of Venezuela in 2001.

Dr. Correa is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.